Table of Content

1 Study Coverage
1.1 Oral Proteins and Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Oral Proteins and Peptides Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Oral Proteins and Peptides Market by Region
1.4.1 Global Oral Proteins and Peptides Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Oral Proteins and Peptides Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Oral Proteins and Peptides Revenue by Players
2.1.1 Global Oral Proteins and Peptides Revenue by Players (2018-2023)
2.1.2 Global Oral Proteins and Peptides Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Oral Proteins and Peptides Revenue in 2023
2.2 Global Oral Proteins and Peptides Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Oral Proteins and Peptides Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Ironwood & Allergan
3.1.1 Ironwood & Allergan Information
3.1.2 Ironwood & Allergan Overview
3.1.3 Ironwood & Allergan Oral Proteins and Peptides Revenue and Gross Margin (2018-2023)
3.1.4 Ironwood & Allergan Related Developments
3.2 Novo Nordisk
3.2.1 Novo Nordisk Information
3.2.2 Novo Nordisk Overview
3.2.3 Novo Nordisk Oral Proteins and Peptides Revenue and Gross Margin (2018-2023)
3.2.4 Novo Nordisk Related Developments
3.3 Synergy Pharmaceuticals ?Salix?
3.3.1 Synergy Pharmaceuticals ?Salix? Information
3.3.2 Synergy Pharmaceuticals ?Salix? Overview
3.3.3 Synergy Pharmaceuticals ?Salix? Oral Proteins and Peptides Revenue and Gross Margin (2018-2023)
3.3.4 Synergy Pharmaceuticals ?Salix? Related Developments
3.4 Novartis
3.4.1 Novartis Information
3.4.2 Novartis Overview
3.4.3 Novartis Oral Proteins and Peptides Revenue and Gross Margin (2018-2023)
3.4.4 Novartis Related Developments
3.5 Chiasma (Amryt Pharma)
3.5.1 Chiasma (Amryt Pharma) Information
3.5.2 Chiasma (Amryt Pharma) Overview
3.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Revenue and Gross Margin (2018-2023)
3.5.4 Chiasma (Amryt Pharma) Related Developments
4 Market Size by Type
4.1 Global Oral Proteins and Peptides Revenue by Type
4.2 Global Oral Proteins and Peptides Market Size Growth by Type 2018-2023
5 Market Size by Application
5.1 Global Oral Proteins and Peptides Revenue by Application
5.2 Global Oral Proteins and Peptides Market Size Growth by Application 2018-2023
6 Global Oral Proteins and Peptides Market Insights
6.1 Global Oral Proteins and Peptides Market Revenue 2018-2023
6.2 Global Oral Proteins and Peptides Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Oral Proteins and Peptides Market Size by Country
7.1.1 Americas Oral Proteins and Peptides Revenue by Country (2018-2023)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Oral Proteins and Peptides Market Size by Country
8.1.1 Europe Oral Proteins and Peptides Revenue by Country (2018-2023)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Oral Proteins and Peptides Market Size by Region
9.1.1 Asia Pacific Oral Proteins and Peptides Revenue by Region (2018-2023)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Oral Proteins and Peptides Market Size by Country
10.1.1 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2018-2023)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Oral Proteins and Peptides Industry Trends
11.2 Oral Proteins and Peptides Market Drivers
11.3 Oral Proteins and Peptides Market Challenges
11.4 Oral Proteins and Peptides Market Restraints
12 Oral Proteins and Peptides Forecasted Market Size by Type
12.1 Global Oral Proteins and Peptides Forecasted Revenue by Type
12.2 Global Oral Proteins and Peptides Forecasted Market Size Growth by Type 2023-2029
13 Oral Proteins and Peptides Forecasted Market Size by Application
13.1 Global Oral Proteins and Peptides Forecasted Revenue by Application
13.2 Global Oral Proteins and Peptides Forecasted Market Size Growth by Application 2023-2029
14 Global Oral Proteins and Peptides Market Forecasts
14.1 Global Oral Proteins and Peptides Market Revenue Forecasts 2023-2029
14.2 Global Oral Proteins and Peptides Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Oral Proteins and Peptides Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Oral Proteins and Peptides Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Oral Proteins and Peptides Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Oral Proteins and Peptides Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer